Persistent viral infections remodel host metabolism to sustain viral replication, evade immunity, and persist long term. Studies by Matthew G. Vander Heiden Massachusetts Institute of Technology and Andrew Mehle University of Wisconsin–Madison document how diverse viruses shift cellular nutrient use and signaling to favor biosynthesis of nucleotides, lipids, and energy. These shifts are not uniform; they depend on viral species, infected cell type, and the host’s nutritional and immune state.
Mechanisms of metabolic reprogramming
Viruses commonly increase flux through glycolysis to supply ATP and carbon skeletons for biosynthesis, while diverting intermediates into the pentose phosphate pathway for nucleotide synthesis. They also upregulate glutaminolysis to replenish tricarboxylic acid cycle intermediates and support anabolic needs. Alterations in lipogenesis enable membrane biogenesis for viral replication complexes and virion envelopes. At the organelle level, viruses manipulate mitochondrial dynamics and electron transport to modulate reactive oxygen species and apoptosis thresholds. Key host signaling hubs such as mTOR and AMP activated protein kinase are co-opted to create anabolism-favoring states. Vander Heiden at Massachusetts Institute of Technology highlights metabolite tracing as evidence that infected cells rewire carbon flow, and Mehle at University of Wisconsin–Madison emphasizes changes in lipid and redox metabolism during persistent infection. These mechanisms can vary between lytic and latent stages and between cell types such as hepatocytes, macrophages, and neurons.
Consequences for host biology and society
Metabolic remodeling has direct consequences for tissue function and disease risk. Chronic perturbation of lipid and glucose handling can promote organ fibrosis, immunometabolic dysfunction, and in some cases increase cancer risk as seen with persistent hepatitis virus infections and hepatocellular carcinoma. At the population level, persistent viral infections intersect with socioeconomic and environmental factors: undernutrition, coexisting infections, and limited access to care amplify metabolic and clinical harms in marginalized communities. From a therapeutic perspective, host metabolic enzymes present actionable targets; however, targeting metabolism risks unintended effects on immune cells and normal tissue homeostasis, requiring careful balancing in drug development.
Understanding these pathways clarifies why persistent infections are more than viral persistence: they are sustained metabolic states that reshape host physiology, with implications for diagnostics, antiviral strategies, and public health interventions that must consider both molecular mechanisms and social determinants.